On September 20, 1938, the German chemist, Dr. Otto Roelen, then the research director at Ruhrchemie in Oberhausen (now Oxea), filed a patent application for the oxo synthesis.
Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International